» Articles » PMID: 33559868

ERO1α Mediates Endoplasmic Reticulum Stress-induced Apoptosis Via MicroRNA-101/EZH2 Axis in Colon Cancer RKO and HT-29 Cells

Overview
Journal Hum Cell
Publisher Springer
Specialty Cell Biology
Date 2021 Feb 9
PMID 33559868
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Although colon cancer is a leading and typical gastrointestinal tumor, there is little published data on the underlying molecular mechanisms of endoplasmic reticulum (ER) stress. Here, we investigated the role of ERO1α and its impact on microRNA (miR)-101 expression and ER stress in colon cancer cells. Cell ER stress was established by treating RKO or HT-29 cells with 1 μM thapsigargin (THG). Cell biological behaviors were detected using CCK-8, bromodeoxyuridine assay, flow cytometry and western blot. We also investigated the expression of ERO1α and miR-101 after THG treatment using RT-qPCR. Moreover, effects of ERO1α and miR-101 on ER stress of colon cancer cells were detected. Additionally, miR-101 impact on EZH2 expression and relevance of this regulation was confirmed by RT-qPCR and luciferase reporter. The regulation of miR-101/EZH2 axis and Wnt/β-catenin pathway in ER stress were investigated. Our results demonstrated that THG induced ER stress in colon cancer cells. Silencing ERO1α further promoted ER stress-induced cell apoptosis. ERO1α knockdown up-regulated miR-101 expression and promoted colon cancer cell apoptosis via regulating miR-101. Surprisingly, miR-101 negatively regulated EZH2 expression via miRNA-mRNA targeting. Moreover, ER stress promoted colon cancer cell apoptosis via regulating miR-101/EZH2 axis. Wnt/β-catenin pathway was also involved in the regulation of ERO1α/miR-101/EZH2 in ER stress of colon cancer cells. These findings illustrated that silencing ERO1α regulated ER stress-induced apoptosis via miR-101/EZH2 axis in RKO and HT-29 cells.

Citing Articles

Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1α) in human cancer.

Chen P, Sharma A, Weiher H, Schmidt-Wolf I J Exp Clin Cancer Res. 2024; 43(1):71.

PMID: 38454454 PMC: 10921667. DOI: 10.1186/s13046-024-02990-4.


Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.

Wei Q, Jiang X, Miao X, Zhang Y, Chen F, Zhang P J Cancer Res Clin Oncol. 2023; 149(13):11351-11368.

PMID: 37378675 DOI: 10.1007/s00432-023-05000-w.


MiR-101: An Important Regulator of Gene Expression and Tumor Ecosystem.

Liu N, Yang C, Gao A, Sun M, Lv D Cancers (Basel). 2022; 14(23).

PMID: 36497343 PMC: 9739992. DOI: 10.3390/cancers14235861.


MicroRNA-218-5p affects lung adenocarcinoma progression through targeting endoplasmic reticulum oxidoreductase 1 alpha.

Chen G, Wang Q, Wang K Bioengineered. 2022; 13(4):10061-10070.

PMID: 35441565 PMC: 9161986. DOI: 10.1080/21655979.2022.2063537.

References
1.
Banerjee A, Pathak S, Subramanium V, G D, Murugesan R, Verma R . Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives. Drug Discov Today. 2017; 22(8):1224-1232. DOI: 10.1016/j.drudis.2017.05.006. View

2.
Liu F, Tong T, Huang D, Yuan W, Li D, Lin J . CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomised controlled phase III trial. BMJ Open. 2019; 9(1):e017637. PMC: 6352769. DOI: 10.1136/bmjopen-2017-017637. View

3.
Freeman H . Early stage colon cancer. World J Gastroenterol. 2014; 19(46):8468-73. PMC: 3870492. DOI: 10.3748/wjg.v19.i46.8468. View

4.
Wong R . Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011; 30:87. PMC: 3197541. DOI: 10.1186/1756-9966-30-87. View

5.
Huerta S, Goulet E, Livingston E . Colon cancer and apoptosis. Am J Surg. 2006; 191(4):517-26. DOI: 10.1016/j.amjsurg.2005.11.009. View